[
  {
    "ts": "2026-02-27T03:17:29+00:00",
    "headline": "Evaluating Elevance Health (ELV) After Prolonged Share Price Weakness And 17.3% Undervaluation Estimate",
    "summary": "With no single headline event driving attention, Elevance Health (ELV) has drawn investor interest after a mixed share price record, including a 16.18% decline over the past year and a 27.89% decline over three years. See our latest analysis for Elevance Health. Recent trading has been soft, with a 7 day share price return of 7.22% and a year to date share price return decline of 8.81%, while the 1 year total shareholder return decline of 16.18% and 3 year total shareholder return decline of...",
    "url": "https://finance.yahoo.com/news/evaluating-elevance-health-elv-prolonged-031729043.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "f06cdf46-21cd-3396-be25-8c2f6c22f282",
      "content": {
        "id": "f06cdf46-21cd-3396-be25-8c2f6c22f282",
        "contentType": "STORY",
        "title": "Evaluating Elevance Health (ELV) After Prolonged Share Price Weakness And 17.3% Undervaluation Estimate",
        "description": "",
        "summary": "With no single headline event driving attention, Elevance Health (ELV) has drawn investor interest after a mixed share price record, including a 16.18% decline over the past year and a 27.89% decline over three years. See our latest analysis for Elevance Health. Recent trading has been soft, with a 7 day share price return of 7.22% and a year to date share price return decline of 8.81%, while the 1 year total shareholder return decline of 16.18% and 3 year total shareholder return decline of...",
        "pubDate": "2026-02-27T03:17:29Z",
        "displayTime": "2026-02-27T03:17:29Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/En2KzBqo8SXnCw89zK0WLw--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/BoUVqO_whCETSPZRsj9Bbg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/3e695c35ab2bf9c83822def1d840a300.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/evaluating-elevance-health-elv-prolonged-031729043.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evaluating-elevance-health-elv-prolonged-031729043.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ELV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]